share_log

Psyched: LSD For Major Depression, Canada's Large Scale Psilocybin Macrodose Trial, Treatments For Autism Spectrum Disorder And Multiple Sclerosis And More

Benzinga ·  Apr 25, 2023 03:58

LSD Trial Study Shows Potential For Major Depression

  • Psychedelics biopharma companyMind Medicine Inc.(NASDAQ:MNMD) recently shared positive topline data from an advanced clinical trial of LSDas a treatment of Major Depressive Disorder (MDD).
  • The double-blind Phase 2 study demonstrated "significant, rapid, durable and beneficial effects" on the mitigation of MDD symptoms.Read more HERE.

Canada's Large Scale Psilocybin Macrodose Trial

  • Canadian biopharma companyApex Labs Ltd.,has received Health Canada's approval for a comprehensive, "statistically powered" macro-and-multi dose advanced psilocybin trial on 160 patients.
  • The trial's primary indication (severe depression within PTSD) is...
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment